An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement
Introduction Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating...
Gespeichert in:
Veröffentlicht in: | Archives of orthopaedic and trauma surgery 2014-03, Vol.134 (3), p.413-420 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 420 |
---|---|
container_issue | 3 |
container_start_page | 413 |
container_title | Archives of orthopaedic and trauma surgery |
container_volume | 134 |
creator | Assmann, G. Kasch, R. Hofer, A. Schulz, A. P. Kayser, R. Lahm, A. Merk, H. Flessa, S. |
description | Introduction
Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating department’s perspective. We here provide a detailed analysis of the costs of THR revision and relate them to reimbursement underlying the German diagnosis-related groups (DRG) system.
Materials and methods
Major cost parameters were identified using for orientation the cost matrix of the German Institute for Hospital Reimbursement (InEK GmbH). We then retrospectively analysed the major direct costs of aseptic revision THR in terms of contribution margins I and II. The analysis included a total of 114 patients who underwent aseptic revision from 1 January 2009 to 31 March 2012. Data were retrieved from the hospital information system and patient records. All costs of surgery, diagnostic tests, and other treatments were calculated as purchase prices in EUR. The comparative analysis of direct costs and reimbursements was done for DRG I46A and I46B from the hospital’s, especially treating department’s rather than the society or healthcare insurance’s perspective.
Results
The average direct cost incurred by the hospital for a THR revision was €4,380.0. The largest share was accounted for surgical costs (62.7 % of total). Implant and staff costs were identified as the most important factors that can be influenced. The proportion of the daily contribution margin that was left to cover the hospital’s indirect cost decreased with the relative cost weight of the DRG to which a patient was assigned.
Conclusion
Our study for the first time provides a detailed analysis of the major direct case costs of THR revision for aseptic loosening from the provider’s perspective. Our findings suggest that these revision operations could be performed cost-beneficially by the operating unit. From an economic perspective, cases with higher cost weights are more favorable for a hospital. These results need to be confirmed in multicenter studies. |
doi_str_mv | 10.1007/s00402-014-1920-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1500689517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2261979824</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-4b9baf8e722085d0d3d436aa2f8a09a6fe5468e37ce659e4da1e67c535f5e33c3</originalsourceid><addsrcrecordid>eNp1kU-LFDEQxYMo7uzqB_AiDV720m7lT3c63pbBdYWFveg5ZNLVTpbuTptKC3Pwu5thRgXBUxX1fu8F8hh7w-E9B9A3BKBA1MBVzY2AGp6xDVdS1dLw9jnbgJFt3UHDL9gl0RMAF52Bl-xCKKW16PSG_bydK_RxjlPwlZvdeKBAVRwqR7jkckv4I1CIc7UPS-VS3qe4jI7y4UO1daNfR5ePanEsRQ1urPaRlpDL4iNlqsJcMs5UjmUP025NhBPO-RV7MbiR8PV5XrGvdx-_bO_rh8dPn7e3D7WXWuRa7czODR1qIaBreuhlr2TrnBg6B8a1Azaq7VBqj21jUPWOY6t9I5uhQSm9vGLXp9wlxe8rUrZTII_j6GaMK1neALSdabgu6Lt_0Ke4pvIxZIVoudGmE6pQ_ET5FIkSDnZJYXLpYDnYYzf21I0t3dhjNxaK5-05ed1N2P9x_C6jAOIEUJHmb5j-Pv3_1F-o0Zuc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2261979824</pqid></control><display><type>article</type><title>An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Assmann, G. ; Kasch, R. ; Hofer, A. ; Schulz, A. P. ; Kayser, R. ; Lahm, A. ; Merk, H. ; Flessa, S.</creator><creatorcontrib>Assmann, G. ; Kasch, R. ; Hofer, A. ; Schulz, A. P. ; Kayser, R. ; Lahm, A. ; Merk, H. ; Flessa, S.</creatorcontrib><description>Introduction
Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating department’s perspective. We here provide a detailed analysis of the costs of THR revision and relate them to reimbursement underlying the German diagnosis-related groups (DRG) system.
Materials and methods
Major cost parameters were identified using for orientation the cost matrix of the German Institute for Hospital Reimbursement (InEK GmbH). We then retrospectively analysed the major direct costs of aseptic revision THR in terms of contribution margins I and II. The analysis included a total of 114 patients who underwent aseptic revision from 1 January 2009 to 31 March 2012. Data were retrieved from the hospital information system and patient records. All costs of surgery, diagnostic tests, and other treatments were calculated as purchase prices in EUR. The comparative analysis of direct costs and reimbursements was done for DRG I46A and I46B from the hospital’s, especially treating department’s rather than the society or healthcare insurance’s perspective.
Results
The average direct cost incurred by the hospital for a THR revision was €4,380.0. The largest share was accounted for surgical costs (62.7 % of total). Implant and staff costs were identified as the most important factors that can be influenced. The proportion of the daily contribution margin that was left to cover the hospital’s indirect cost decreased with the relative cost weight of the DRG to which a patient was assigned.
Conclusion
Our study for the first time provides a detailed analysis of the major direct case costs of THR revision for aseptic loosening from the provider’s perspective. Our findings suggest that these revision operations could be performed cost-beneficially by the operating unit. From an economic perspective, cases with higher cost weights are more favorable for a hospital. These results need to be confirmed in multicenter studies.</description><identifier>ISSN: 0936-8051</identifier><identifier>EISSN: 1434-3916</identifier><identifier>DOI: 10.1007/s00402-014-1920-0</identifier><identifier>PMID: 24477287</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Aged, 80 and over ; Arthroplasty, Replacement, Hip - adverse effects ; Arthroplasty, Replacement, Hip - economics ; Arthroplasty, Replacement, Hip - statistics & numerical data ; Diagnosis-Related Groups - economics ; Economic analysis ; Female ; Germany ; Hip Arthroplasty ; Hospital Costs ; Humans ; Insurance, Health, Reimbursement - economics ; Joint Prosthesis - adverse effects ; Joint Prosthesis - economics ; Joint surgery ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Orthopedics ; Prosthesis Failure ; Reoperation - economics ; Retrospective Studies</subject><ispartof>Archives of orthopaedic and trauma surgery, 2014-03, Vol.134 (3), p.413-420</ispartof><rights>Springer-Verlag Berlin Heidelberg 2014</rights><rights>Archives of Orthopaedic and Trauma Surgery is a copyright of Springer, (2014). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-4b9baf8e722085d0d3d436aa2f8a09a6fe5468e37ce659e4da1e67c535f5e33c3</citedby><cites>FETCH-LOGICAL-c372t-4b9baf8e722085d0d3d436aa2f8a09a6fe5468e37ce659e4da1e67c535f5e33c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00402-014-1920-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00402-014-1920-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24477287$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Assmann, G.</creatorcontrib><creatorcontrib>Kasch, R.</creatorcontrib><creatorcontrib>Hofer, A.</creatorcontrib><creatorcontrib>Schulz, A. P.</creatorcontrib><creatorcontrib>Kayser, R.</creatorcontrib><creatorcontrib>Lahm, A.</creatorcontrib><creatorcontrib>Merk, H.</creatorcontrib><creatorcontrib>Flessa, S.</creatorcontrib><title>An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement</title><title>Archives of orthopaedic and trauma surgery</title><addtitle>Arch Orthop Trauma Surg</addtitle><addtitle>Arch Orthop Trauma Surg</addtitle><description>Introduction
Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating department’s perspective. We here provide a detailed analysis of the costs of THR revision and relate them to reimbursement underlying the German diagnosis-related groups (DRG) system.
Materials and methods
Major cost parameters were identified using for orientation the cost matrix of the German Institute for Hospital Reimbursement (InEK GmbH). We then retrospectively analysed the major direct costs of aseptic revision THR in terms of contribution margins I and II. The analysis included a total of 114 patients who underwent aseptic revision from 1 January 2009 to 31 March 2012. Data were retrieved from the hospital information system and patient records. All costs of surgery, diagnostic tests, and other treatments were calculated as purchase prices in EUR. The comparative analysis of direct costs and reimbursements was done for DRG I46A and I46B from the hospital’s, especially treating department’s rather than the society or healthcare insurance’s perspective.
Results
The average direct cost incurred by the hospital for a THR revision was €4,380.0. The largest share was accounted for surgical costs (62.7 % of total). Implant and staff costs were identified as the most important factors that can be influenced. The proportion of the daily contribution margin that was left to cover the hospital’s indirect cost decreased with the relative cost weight of the DRG to which a patient was assigned.
Conclusion
Our study for the first time provides a detailed analysis of the major direct case costs of THR revision for aseptic loosening from the provider’s perspective. Our findings suggest that these revision operations could be performed cost-beneficially by the operating unit. From an economic perspective, cases with higher cost weights are more favorable for a hospital. These results need to be confirmed in multicenter studies.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Arthroplasty, Replacement, Hip - adverse effects</subject><subject>Arthroplasty, Replacement, Hip - economics</subject><subject>Arthroplasty, Replacement, Hip - statistics & numerical data</subject><subject>Diagnosis-Related Groups - economics</subject><subject>Economic analysis</subject><subject>Female</subject><subject>Germany</subject><subject>Hip Arthroplasty</subject><subject>Hospital Costs</subject><subject>Humans</subject><subject>Insurance, Health, Reimbursement - economics</subject><subject>Joint Prosthesis - adverse effects</subject><subject>Joint Prosthesis - economics</subject><subject>Joint surgery</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Orthopedics</subject><subject>Prosthesis Failure</subject><subject>Reoperation - economics</subject><subject>Retrospective Studies</subject><issn>0936-8051</issn><issn>1434-3916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU-LFDEQxYMo7uzqB_AiDV720m7lT3c63pbBdYWFveg5ZNLVTpbuTptKC3Pwu5thRgXBUxX1fu8F8hh7w-E9B9A3BKBA1MBVzY2AGp6xDVdS1dLw9jnbgJFt3UHDL9gl0RMAF52Bl-xCKKW16PSG_bydK_RxjlPwlZvdeKBAVRwqR7jkckv4I1CIc7UPS-VS3qe4jI7y4UO1daNfR5ePanEsRQ1urPaRlpDL4iNlqsJcMs5UjmUP025NhBPO-RV7MbiR8PV5XrGvdx-_bO_rh8dPn7e3D7WXWuRa7czODR1qIaBreuhlr2TrnBg6B8a1Azaq7VBqj21jUPWOY6t9I5uhQSm9vGLXp9wlxe8rUrZTII_j6GaMK1neALSdabgu6Lt_0Ke4pvIxZIVoudGmE6pQ_ET5FIkSDnZJYXLpYDnYYzf21I0t3dhjNxaK5-05ed1N2P9x_C6jAOIEUJHmb5j-Pv3_1F-o0Zuc</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Assmann, G.</creator><creator>Kasch, R.</creator><creator>Hofer, A.</creator><creator>Schulz, A. P.</creator><creator>Kayser, R.</creator><creator>Lahm, A.</creator><creator>Merk, H.</creator><creator>Flessa, S.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20140301</creationdate><title>An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement</title><author>Assmann, G. ; Kasch, R. ; Hofer, A. ; Schulz, A. P. ; Kayser, R. ; Lahm, A. ; Merk, H. ; Flessa, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-4b9baf8e722085d0d3d436aa2f8a09a6fe5468e37ce659e4da1e67c535f5e33c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Arthroplasty, Replacement, Hip - adverse effects</topic><topic>Arthroplasty, Replacement, Hip - economics</topic><topic>Arthroplasty, Replacement, Hip - statistics & numerical data</topic><topic>Diagnosis-Related Groups - economics</topic><topic>Economic analysis</topic><topic>Female</topic><topic>Germany</topic><topic>Hip Arthroplasty</topic><topic>Hospital Costs</topic><topic>Humans</topic><topic>Insurance, Health, Reimbursement - economics</topic><topic>Joint Prosthesis - adverse effects</topic><topic>Joint Prosthesis - economics</topic><topic>Joint surgery</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Orthopedics</topic><topic>Prosthesis Failure</topic><topic>Reoperation - economics</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Assmann, G.</creatorcontrib><creatorcontrib>Kasch, R.</creatorcontrib><creatorcontrib>Hofer, A.</creatorcontrib><creatorcontrib>Schulz, A. P.</creatorcontrib><creatorcontrib>Kayser, R.</creatorcontrib><creatorcontrib>Lahm, A.</creatorcontrib><creatorcontrib>Merk, H.</creatorcontrib><creatorcontrib>Flessa, S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of orthopaedic and trauma surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Assmann, G.</au><au>Kasch, R.</au><au>Hofer, A.</au><au>Schulz, A. P.</au><au>Kayser, R.</au><au>Lahm, A.</au><au>Merk, H.</au><au>Flessa, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement</atitle><jtitle>Archives of orthopaedic and trauma surgery</jtitle><stitle>Arch Orthop Trauma Surg</stitle><addtitle>Arch Orthop Trauma Surg</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>134</volume><issue>3</issue><spage>413</spage><epage>420</epage><pages>413-420</pages><issn>0936-8051</issn><eissn>1434-3916</eissn><abstract>Introduction
Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating department’s perspective. We here provide a detailed analysis of the costs of THR revision and relate them to reimbursement underlying the German diagnosis-related groups (DRG) system.
Materials and methods
Major cost parameters were identified using for orientation the cost matrix of the German Institute for Hospital Reimbursement (InEK GmbH). We then retrospectively analysed the major direct costs of aseptic revision THR in terms of contribution margins I and II. The analysis included a total of 114 patients who underwent aseptic revision from 1 January 2009 to 31 March 2012. Data were retrieved from the hospital information system and patient records. All costs of surgery, diagnostic tests, and other treatments were calculated as purchase prices in EUR. The comparative analysis of direct costs and reimbursements was done for DRG I46A and I46B from the hospital’s, especially treating department’s rather than the society or healthcare insurance’s perspective.
Results
The average direct cost incurred by the hospital for a THR revision was €4,380.0. The largest share was accounted for surgical costs (62.7 % of total). Implant and staff costs were identified as the most important factors that can be influenced. The proportion of the daily contribution margin that was left to cover the hospital’s indirect cost decreased with the relative cost weight of the DRG to which a patient was assigned.
Conclusion
Our study for the first time provides a detailed analysis of the major direct case costs of THR revision for aseptic loosening from the provider’s perspective. Our findings suggest that these revision operations could be performed cost-beneficially by the operating unit. From an economic perspective, cases with higher cost weights are more favorable for a hospital. These results need to be confirmed in multicenter studies.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>24477287</pmid><doi>10.1007/s00402-014-1920-0</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0936-8051 |
ispartof | Archives of orthopaedic and trauma surgery, 2014-03, Vol.134 (3), p.413-420 |
issn | 0936-8051 1434-3916 |
language | eng |
recordid | cdi_proquest_miscellaneous_1500689517 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Aged Aged, 80 and over Arthroplasty, Replacement, Hip - adverse effects Arthroplasty, Replacement, Hip - economics Arthroplasty, Replacement, Hip - statistics & numerical data Diagnosis-Related Groups - economics Economic analysis Female Germany Hip Arthroplasty Hospital Costs Humans Insurance, Health, Reimbursement - economics Joint Prosthesis - adverse effects Joint Prosthesis - economics Joint surgery Male Medicine Medicine & Public Health Middle Aged Orthopedics Prosthesis Failure Reoperation - economics Retrospective Studies |
title | An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T15%3A23%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20economic%20analysis%20of%20aseptic%20revision%20hip%20arthroplasty:%20Calculation%20of%20partial%20hospital%20costs%20in%20relation%20to%20reimbursement&rft.jtitle=Archives%20of%20orthopaedic%20and%20trauma%20surgery&rft.au=Assmann,%20G.&rft.date=2014-03-01&rft.volume=134&rft.issue=3&rft.spage=413&rft.epage=420&rft.pages=413-420&rft.issn=0936-8051&rft.eissn=1434-3916&rft_id=info:doi/10.1007/s00402-014-1920-0&rft_dat=%3Cproquest_cross%3E2261979824%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2261979824&rft_id=info:pmid/24477287&rfr_iscdi=true |